[
  {
    "ts": null,
    "headline": "Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger",
    "summary": "Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.",
    "url": "https://finnhub.io/api/news?id=d6ae862d5e5c0c120bd48c57d94f370776bf6abba63b13b6bfaae389695ad78a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732968000,
      "headline": "Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger",
      "id": 131724710,
      "image": "",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.",
      "url": "https://finnhub.io/api/news?id=d6ae862d5e5c0c120bd48c57d94f370776bf6abba63b13b6bfaae389695ad78a"
    }
  }
]